Inhibition of Wnt/β-catenin-WISP1 signaling by carnosic acid (CA) disrupts the GSC maintenance, inhibits survival of tumor-supportive TAMs, and suppresses GBM growth, suggesting that targeting this signaling axis may effectively improve GBM treatment. This evidence concerns the gene CCN4 and glioblastoma.